Selective Endocannabinoid Reuptake Inhibitor WOBE437 Reduces Disease Progression in a Mouse Model of Multiple Sclerosis

por Reynoso-Moreno, Ines, Tietz, Silvia, Vallini, Erika, Engelhardt, Britta, Gertsch, Jürg, Chicca, Andrea
Publicado 2021